{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05879913",
            "orgStudyIdInfo": {
                "id": "CTO-IUSCCC-0807"
            },
            "organization": {
                "fullName": "Indiana University",
                "class": "OTHER"
            },
            "briefTitle": "ASCVD Management Using CCTA in Prostate Cancer Patients on ADT",
            "officialTitle": "Personalized Medical Treatment of Coronary Atherosclerosis in Prostate Cancer Patients Guided by Plaque Assessment With Quantitative Coronary CT Angiography (CCTA)",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "ascvd-management-using-ccta-in-prostate-cancer-patients-on-adt"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-04",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-12-15",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-12",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-12",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-05-19",
            "studyFirstSubmitQcDate": "2023-05-19",
            "studyFirstPostDateStruct": {
                "date": "2023-05-30",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-04-30",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-01",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Suparna C. Clasen",
                "investigatorTitle": "Medical Director of Cardio-Oncology, Assistant Professor in the Department of Medicine at Indiana University",
                "investigatorAffiliation": "Indiana University"
            },
            "leadSponsor": {
                "name": "Indiana University",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "National Comprehensive Cancer Network",
                    "class": "NETWORK"
                },
                {
                    "name": "Pfizer",
                    "class": "INDUSTRY"
                },
                {
                    "name": "Myovant Sciences GmbH",
                    "class": "INDUSTRY"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": true
        },
        "descriptionModule": {
            "briefSummary": "This is a randomized pilot study of Coronary CT Angiography (CCTA) for coronary atherosclerosis vs. Usual Care in patients with prostate cancer who are either planning to begin, or are currently taking androgen deprivation therapy (ADT) .",
            "detailedDescription": "This is a randomized pilot study where subjects are randomized 1:1 to either the CCTA group or non-CCTA (usual care) group. The target enrollment will be 100 subjects with accounting for a potential 10% dropout rate resulting in an sample size between 90-100 participants or 45-50per group arm."
        },
        "conditionsModule": {
            "conditions": [
                "Prostate Cancer"
            ],
            "keywords": [
                "Prostate Cancer",
                "Coronary Atherosclerosis",
                "Quantitative Coronary CT Angiography",
                "Androgen Deprivation Therapy"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "DIAGNOSTIC",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 100,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "CCTA Group",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Device: Coronary CT Angiography (CCTA)"
                    ]
                },
                {
                    "label": "Usual Care Group",
                    "type": "NO_INTERVENTION"
                }
            ],
            "interventions": [
                {
                    "type": "DEVICE",
                    "name": "Coronary CT Angiography (CCTA)",
                    "description": "Coronary computed tomographic angiography (CCTA) scan is a highly accurate noninvasive technique for detection of coronary artery plaque.",
                    "armGroupLabels": [
                        "CCTA Group"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Proportion of Atherosclerosis in CCTA Arm",
                    "description": "Proportion of prostate cancer patients without cardiac symptoms in the CCTA arm who are reclassified into a higher risk group using automated plaque assessment from CCTA that would otherwise be classed as low risk for ASCVD using the PCE",
                    "timeFrame": "Baseline"
                },
                {
                    "measure": "Proportion of Subjects Eligible for Treatment Based on Automated Plaque Assessment from CCTA",
                    "description": "Assessment of automated plaque from CCTA determining eligibility of lipid lowering treatment and aspirin",
                    "timeFrame": "Baseline"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Reduction in atherosclerotic cardiovascular disease (ASCVD) risk score",
                    "description": "Changes in risk over time with intensive medical treatment tailored to plaque burden to test results in a reduction in cardiovascular risk factors including blood pressure, glucose and lipid levels, thus reducing the ASCVD risk score.",
                    "timeFrame": "Baseline, 6 months, and 12 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. Written informed consent and HIPAA authorization for release of personal health information\n2. Age \u226540 years at time of consent\n3. Previous diagnosis of prostate cancer who are either currently receiving ADT, or who are planning to start ADT for \\>12 months\n4. Patients currently on or planned for treatment with ADT plus androgen pathway inhibitor (abiraterone, enzalutamide, apalutamide, darolutamide) are allowed\n5. \u22651 risk factor for ASCVD (hypertension, hyperlipidemia, diabetes, tobacco use)\n6. No current cardiac symptoms\n\nExclusion Criteria:\n\n1. Concurrent treatment with chemotherapy (docetaxel, cabazitaxel, mitoxantrone) at time of signing consent\n2. Patient has implantable cardioverter-defibrillator (ICD), or pacemaker\n3. History of coronary stents, obstructive coronary artery disease, myocardial infarction, coronary artery bypass grafting. History of atrial fibrillation\n4. Renal dysfunction with creatinine clearance \\<35ml/min (calculated by Cockcroft-Gault Equation)\n5. Allergy to iodinated contrast\n6. Contraindication to the medications that may be given to regulate heart rate for the CCTA scan (applicable only to those randomized to the CCTA group)\n7. Patients taking sildenafil or tadalafil for vasodilation, pulmonary hypertension, or BPH\n\n   1. Note: Subjects taking sildenafil or tadalafil for erectile disfunction will still be eligible.",
            "healthyVolunteers": false,
            "sex": "MALE",
            "minimumAge": "40 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Nishant M. Chenchaiah",
                    "role": "CONTACT",
                    "phone": "317-278-0070",
                    "email": "nischenc@iu.edu"
                },
                {
                    "name": "Suparna C. Clasen, MD, MSCE",
                    "role": "CONTACT",
                    "phone": "(317) 963-5462",
                    "email": "scclasen@iu.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Suparna C. Clasen, MD, MSCE",
                    "affiliation": "Indiana University",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Indiana University Melvin and Bren Simon Comprehensive Cancer Center",
                    "status": "RECRUITING",
                    "city": "Indianapolis",
                    "state": "Indiana",
                    "zip": "46202",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Nishant M. Chenchaiah",
                            "role": "CONTACT",
                            "phone": "317-278-0070",
                            "email": "nischenc@iu.edu"
                        },
                        {
                            "name": "Nabil Adra, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.76838,
                        "lon": -86.15804
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000011471",
                    "term": "Prostatic Neoplasms"
                }
            ],
            "ancestors": [
                {
                    "id": "D000005834",
                    "term": "Genital Neoplasms, Male"
                },
                {
                    "id": "D000014565",
                    "term": "Urogenital Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000005832",
                    "term": "Genital Diseases, Male"
                },
                {
                    "id": "D000091662",
                    "term": "Genital Diseases"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                },
                {
                    "id": "D000011469",
                    "term": "Prostatic Diseases"
                },
                {
                    "id": "D000052801",
                    "term": "Male Urogenital Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M6546",
                    "name": "Coronary Artery Disease",
                    "relevance": "LOW"
                },
                {
                    "id": "M19506",
                    "name": "Myocardial Ischemia",
                    "relevance": "LOW"
                },
                {
                    "id": "M26188",
                    "name": "Atherosclerosis",
                    "relevance": "LOW"
                },
                {
                    "id": "M14335",
                    "name": "Prostatic Neoplasms",
                    "asFound": "Prostate Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M8946",
                    "name": "Genital Neoplasms, Male",
                    "relevance": "LOW"
                },
                {
                    "id": "M17315",
                    "name": "Urogenital Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M2876",
                    "name": "Genital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8944",
                    "name": "Genital Diseases, Male",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14333",
                    "name": "Prostatic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27095",
                    "name": "Male Urogenital Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC14",
                    "name": "Heart and Blood Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M4059",
                    "name": "Androgens",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}